Personal information

Other IDs

Scopus Author ID: 57208279596

Activities

Collapse all

Works (13)

Application of the IPDfromKM-Shiny Method to Compare the Efficacy of Novel Treatments Aimed at the Same Disease Condition: A Report of 14 Analyses

Cancers
2023-03-07 | Journal article
DOI: 10.3390/cancers15061633
Contributors: Andrea Messori; Vera Damuzzo; Melania Rivano; Luca Cancanelli; Lorenzo Di Spazio; Andrea Ossato; Marco Chiumente; Daniele Mengato
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Survival in Patients with Relapsed-Refractory Multiple Myeloma: Indirect Comparison of Six New Treatments

Hematology Reports
2023-01-13 | Journal article
DOI: 10.3390/hematolrep15010006
Contributors: Luca Cancanelli; Melania Rivano; Lorenzo Di Spazio; Marco Chiumente; Daniele Mengato; Andrea Messori
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Evaluation of maintenance treatment with PARP inhibitors in ovarian carcinoma patients responding to platinum therapy: Use of restricted mean survival time as an index of efficacy

International journal of clinical pharmacology and therapeutics
2022 | Journal article
DOI: 10.5414/CP204113
EID:

2-s2.0-85123878196

Part of ISSN: 09461965
Contributors: Cancanelli, L.; Mengato, D.; Di Spazio, L.; Rivano, M.; Chiumente, M.; Messori, A.
Source: Self-asserted source
Luca Cancanelli via Scopus - Elsevier

Survival with novel hormonal therapies in patients with nonmetastatic castration-resistant prostate cancer: indirect comparison of three randomized phase-III trials

World Journal of Urology
2022-09-09 | Journal article
DOI: 10.1007/s00345-022-04143-8
Contributors: Melania Rivano; Luca Cancanelli; Lorenzo Di Spazio; Daniele Mengato; Marco Chiumente; Andrea Messori
Source: check_circle
Crossref

First-Line Chemoimmunotherapy Versus Chemotherapy in PD-L1-Negative Patients with Non-Small-Cell Lung Cancer

Immunotherapy
2022-08 | Journal article
DOI: 10.2217/imt-2021-0208
Contributors: Daniele Mengato; Luca Cancanelli; Melania Rivano; Marco Chiumente; Lorenzo Di Spazio; Andrea Messori
Source: check_circle
Crossref

A preliminary estimate of survival gain and cost-effectiveness of CAR-T in adult patients with acute lymphoblastic leukemia

Leukemia & Lymphoma
2022-04-16 | Journal article
DOI: 10.1080/10428194.2021.2022141
Contributors: Andrea Messori; Melania Rivano; Daniele Mengato; Luca Cancanelli; Lorenzo Di Spazio; Marco Chiumente
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)

Journal of Translational Medicine
2021 | Journal article
DOI: 10.1186/s12967-021-03094-9
EID:

2-s2.0-85118187104

Part of ISSN: 14795876
Contributors: Perrone, F.; Piccirillo, M.C.; Ascierto, P.A.; Salvarani, C.; Parrella, R.; Marata, A.M.; Popoli, P.; Ferraris, L.; Marrocco-Trischitta, M.M.; Ripamonti, D. et al.
Source: Self-asserted source
Luca Cancanelli via Scopus - Elsevier

Experience in managing independent clinical research, the best training strategy for future clinical pharmacists: The QOSMOS project

European Journal of Hospital Pharmacy
2021 | Journal article
DOI: 10.1136/ejhpharm-2021-002839
EID:

2-s2.0-85108789563

Part of ISSN: 20479964 20479956
Contributors: Damuzzo, V.; Agnoletto, L.; Rampazzo, R.; Cammalleri, F.; Cancanelli, L.; Chiumente, M.; Costantino, S.; Michielan, S.; Milani, F.; Sartori, A. et al.
Source: Self-asserted source
Luca Cancanelli via Scopus - Elsevier

Restricted mean survival time in advanced non-small cell lung cancer treated with immune checkpoint inhibitors

European Review for Medical and Pharmacological Sciences
2021 | Journal article
DOI: 10.26355/eurrev_202102_25083
EID:

2-s2.0-85102316800

Part of ISSN: 22840729 11283602
Contributors: Di Spazio, L.; Cancanelli, L.; Rivano, M.; Chiumente, M.; Mengato, D.; Messori, A.
Source: Self-asserted source
Luca Cancanelli via Scopus - Elsevier

The QOSMOS Study: Pharmacist-Led Multicentered Observational Study on Quality of Life in Multiple Sclerosis

Neurology International
2021-12-03 | Journal article
DOI: 10.3390/neurolint13040065
Contributors: Vera Damuzzo; Laura Agnoletto; Roberta Rampazzo; Francesca Cammalleri; Luca Cancanelli; Marco Chiumente; Stefano Costantino; Silvia Michielan; Federica Milani; Alessia Sartori et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Restricted Mean Survival Time as Outcome Measure in Advanced Urothelial Bladder Cancer: Analysis of 4 Clinical Studies

Immunotherapy
2021-02 | Journal article
DOI: 10.2217/imt-2020-0160
Contributors: Melania Rivano; Luca Cancanelli; Lorenzo Di Spazio; Marco Chiumente; Daniele Mengato; Andrea Messori
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Tyrosine-kinase inhibitor discontinuation in chronic myeloid leukaemia after deep molecular response: a meta-analysis with meta-regression

Journal of Chemotherapy
2020-07-03 | Journal article
DOI: 10.1080/1120009X.2020.1716492
Contributors: Melania Rivano; Luca Cancanelli; Andrea Zovi; Chiara Addis; Daniele Mengato; Marco Chiumente; Andrea Messori
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Heterogeneity of the Italian residency training in hospital pharmacy: A pilot study from students' perspective

Journal de Pharmacie Clinique
2018 | Journal article
DOI: 10.1684/jpc.2018.0403
EID:

2-s2.0-85064341107

Part of ISSN: 19524064 02911981
Contributors: Damuzzo, V.; Langella, R.; Mengato, D.; Rivano, M.; Lamesta, C.; Cancanelli, L.; Confalonieri, C.; Badiani, B.; Pigozzo, S.; Realdon, N.
Source: Self-asserted source
Luca Cancanelli via Scopus - Elsevier
How many people are using ORCID?